Author

Marwa Akao

Nagoya University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:clinical cohort / trial· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Shingo IwamiiD· 2 shared Shoya IwanamiiD· 2 shared Chikako ShibataiD· 1 shared Daiki TatematsuiD· 1 shared Kenichi MiyataiD· 1 shared Kohei KumegawaiD· 1 shared Liying YangiD· 1 shared Mana Nagamoto· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Shingo IwamiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Plasticity of extrachromosomal DNA segregation during drug adaptation

Chikako Shibata, Kenichi Miyata, Marwa Akao, Kohei Kumegawa, Yumiko Maruyama, Liying Yang, Mana Nagamoto, Ryu‐Suke Nozawa, Toru Hirota, Shingo Iwami, Shoya Iwanami, Reo Maruyama

This study investigates how extrachromosomal DNA (ecDNA) copy numbers change during drug treatment, showing that resistant clones can actively reconfigure segregation behavior rather than relying on pre-existing clones.

Nature Communications · Aug 8, 2026Peer-reviewedCell Biology

Modeling viral shedding and symptom outcomes in oseltamivir-treated experimental influenza infection

Yasuhisa Fujita, Marwa Akao, Daiki Tatematsu, Shingo Iwami, Naotoshi Nakamura, Shoya Iwanami

This study models oseltamivir's effects on viral shedding and symptom outcomes in experimental influenza infections using clinical trial data, finding no significant antiviral efficacy or dose-dependent effects.

PLoS ONE · Feb 10, 2026Peer-reviewedMicrobiology